Drug Approval | April 30, 2026
Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Patalganga plant received zero observation from USFDA earlier
Patalganga plant received zero observation from USFDA earlier
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
The Danish biotech company confirmed the global study will begin in the second half of 2026
Health innovations are viewed more positively than food and agricultural technologies
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Subscribe To Our Newsletter & Stay Updated
